Hansen, Björn M.
,
Ullman, Natalie http://orcid.org/0000-0002-9812-2537
Muschelli, John
Norrving, Bo
Dlugash, Rachel
Avadhani, Radhika
Awad, Issam
Zuccarello, Mario
Ziai, Wendy C.
Hanley, Daniel F.
Thompson, Richard E.
Lindgren, Arne
Funding for this research was provided by:
National Institute of Neurological Disorders and Stroke (U01NS062851, R01NS046309)
National Institutes of Health (U01NS080824, U24TR001609)
Hjärt-Lungfonden
STROKE-Riksförbundet
Sparbanksstiftelsen Färs and Frosta
Article History
First Online: 5 February 2020
Compliance with Ethical Standards
:
: Dr. Hanley reports Grants from NIH/NINDS, non-financial support from Genentech, during the conduct of the study and personal fees from BrainScope, Neurotrope, Op2Lysis, Portola Pharmaceuticals, and medicolegal, outside the submitted work. Dr. Lindgren reports personal fees from Bayer, BMS/Pfizer, Astra Zeneca, Portola, outside the submitted work. Dr. Norrving reports personal fees for DMC work in the Navigate-ESUS trial (Bayer) and in the SOCRATES and THALES trials (Astra Zeneca). The other authors report no conflicts.
: We confirm adherence to ethical guidelines and indicate ethical approvals (IRB) and use of informed consent, as appropriate.